Contenu en pleine largeur
+1 416-961-JOIN (5646)info@JoinAStudy.ca
Facebook page opens in new windowX page opens in new windowInstagram page opens in new windowYouTube page opens in new window
JoinAStudy.ca
JoinAStudy.ca – Help create a healthier future
JoinAStudy.caJoinAStudy.ca
  • Home
  • Études en cours
  • Problèmes de santé
  • Emplacements de l’étude
  • Blogue sur la santé
  • Pourquoi JoinAStudy?
Search:
  • Home
  • Études en cours
  • Problèmes de santé
  • Emplacements de l’étude
  • Blogue sur la santé
  • Pourquoi JoinAStudy?

Archives du jour : <span>mars 22, 2022</span>

You are here:
  1. Home
  2. mars 2022

Semaglutide weight loss

Paxlovid – Pfizer’s New Oral Covid Pill

COVID, Drug Development, Health Canada & FDA, Industry News, Study ResultsPar JoinAStudy Teammars 22, 2022

Canada has approved the first oral COVID-19 treatment that can be taken at home. The drug, an antiviral developed by Pfizer, was found to reduce risk of hospitalization and death by 89 percent in clinical trials.   At the moment, there is a “limited global supply” of the drug, thus Canadian health officials have prioritized the

© Copyright - JoinAStudy.ca, 2018. All rights reserved
Designed by Pixelore.ca

JoinAStudy.ca does not provide medical advice, diagnosis or treatment.

Information Disclaimer | Privacy | Contact Us

Go to Top
  • English
  • Français